ABEO Abeona Therapeutics Inc.
Healthcare$5.49+0.92%ClosedMarket Cap: $312.9M
As of 2026-05-26
Valuation
P/E (TTM)
3.94
PEG
0.02
P/B
2.13
P/S
21.32
EV/EBITDA
4.08
DCF Value
$0.80
FCF Yield
-27.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
51.9%
Operating Margin
-637.9%
Net Margin
454.9%
ROE
41.4%
ROA
33.3%
ROIC
-50.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.7M | 59.1% | $-23.0M | $-17.1M | $— | — |
| Q4 null | $5.4M | 47.7% | $-22.9M | $-20.5M | $— | — |
| FY null | $5.8M | 73.7% | $-89.4M | $71.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-24.0M | $-5.2M | $— | — |
| Q2 null | $400.0K | 75.0% | $-22.8M | $108.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-19.7M | $-12.0M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-16.7M | $-9.3M | $— | — |
| FY null | $0.00 | -Infinity% | $-64.2M | $-63.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-15.3M | $-30.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-17.9M | $7.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-14.3M | $-31.6M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-13.2M | $-16.6M | $-0.65 | — |